EHA Endorsement of ESMO Clinical Practice Guidelines for Diagnosis, Treatment, and Follow-up for Myelodysplastic Syndromes

por van de Loosdrecht, Arjan A., Mandac Smoljanović, Inga
Publicado 2022

Challenging the status flow: how artificial intelligence is advancing diagnosis of myelodysplastic neoplasms

por Duetz, Carolien, Westers, Theresia M., van de Loosdrecht, Arjan A.
Publicado 2023

Divergent Autologous T Cell Responses to Leukaemic Dendritic Cells during Remission in Acute Promyelocytic Leukaemia

por Westers, Theresia M., Houtenbos, Ilse, van de Loosdrecht, Arjan A., Ossenkoppele, Gert J.
Publicado 2005

Management of patients with lower-risk myelodysplastic syndromes

por Brunner, Andrew M., Leitch, Heather A., van de Loosdrecht, Arjan A., Bonadies, Nicolas
Publicado 2022

6-Sulfo LacNAc (Slan) as a Marker for Non-classical Monocytes

por Hofer, Thomas P., van de Loosdrecht, Arjan A., Stahl-Hennig, Christiane, Cassatella, Marco A., Ziegler-Heitbrock, Loems
Publicado 2019

Tumor immune escape in acute myeloid leukemia: Class II-associated invariant chain peptide expression as result of deficient antigen presentation

por van Luijn, Marvin M., Chamuleau, Martine E.D., Ossenkoppele, Gert J., van de Loosdrecht, Arjan A., Marieke van Ham, S.
Publicado 2012

Allogeneic dendritic cell (DC) vaccination as an “off the shelf” treatment to prevent or delay relapse in elderly acute myeloid leukemia patients: results of Phase I/IIa safety and...

por de Gruijl, Tanja, Santegoeds, Saskia, van Wetering, Sandra, Singh, Satwinder Kaur, Hall, Anthony, van de Loosdrecht, Arjan A, Kruisbeek, Ada
Publicado 2013

Thrombomodulin-expressing monocytes are associated with low-risk features in myelodysplastic syndromes and dampen excessive immune activation

por van Leeuwen-Kerkhoff, Nathalie, Westers, Theresia M., Poddighe, Pino J., de Gruijl, Tanja D., Kordasti, Shahram, van de Loosdrecht, Arjan A.
Publicado 2020

Computational flow cytometry as a diagnostic tool in suspected‐myelodysplastic syndromes

por Duetz, Carolien, Van Gassen, Sofie, Westers, Theresia M., van Spronsen, Margot F., Bachas, Costa, Saeys, Yvan, van de Loosdrecht, Arjan A.
Publicado 2021

Differential capacity of human interleukin-4 and interferon-α monocyte-derived dendritic cells for cross-presentation of free versus cell-associated antigen

por Ruben, Jurjen M., Bontkes, Hetty J., Westers, Theresia M., Hooijberg, Erik, Ossenkoppele, Gert J., de Gruijl, Tanja D., van de Loosdrecht, Arjan A.
Publicado 2015

Durable Responses and Survival in High-risk Myelodysplastic Syndrome and Acute Myeloid Leukemia Patients Receiving the Allogeneic Leukemia-derived Dendritic Cell Vaccine DCP-001

por Janssen, Luca L.G., Westers, Theresia M., Rovers, Jeroen, Valk, Peter J.M., Cloos, Jacqueline, de Gruijl, Tanja D., van de Loosdrecht, Arjan A.
Publicado 2023

Human Bone Marrow-Derived Myeloid Dendritic Cells Show an Immature Transcriptional and Functional Profile Compared to Their Peripheral Blood Counterparts and Separate from Slan+ No...

por van Leeuwen-Kerkhoff, Nathalie, Lundberg, Kristina, Westers, Theresia M., Kordasti, Shahram, Bontkes, Hetty J., Lindstedt, Malin, de Gruijl, Tanja D., van de Loosdrecht, Arjan A.
Publicado 2018

Increased prescription rate of anti‐infective agents after diagnosis of myelodysplastic syndromes

por Rozema, Johanne, Hoogendoorn, Mels, Potma, Iris, ten Seldam, Inge, Veeger, Nic J. G. M., Kibbelaar, Robby E., van de Loosdrecht, Arjan A., van Roon, Eric N.
Publicado 2022

Reduced frequencies and functional impairment of dendritic cell subsets and non-classical monocytes in myelodysplastic syndromes

por van Leeuwen-Kerkhoff, Nathalie, Westers, Theresia M., Poddighe, Pino J., Povoleri, Giovanni A.M., Timms, Jessica A., Kordasti, Shahram, de Gruijl, Tanja D., van de Loosdrecht, Arjan A.
Publicado 2021

Dysregulation of developmental and cell type-specific expression of glycoconjugates on hematopoietic cells: a new characteristic of myelodysplastic neoplasms (MDS)

por van Spronsen, Margot F., Horrevorts, Sophie, Cali, Claudia, Westers, Theresia M., Van Gassen, Sofie, Saeys, Yvan, van Vliet, Sandra J., van Kooyk, Yvette, van de Loosdrecht, Arjan A.
Publicado 2023

Targeting Toll-like receptor 7/8 enhances uptake of apoptotic leukemic cells by monocyte-derived dendritic cells but interferes with subsequent cytokine-induced maturation

por van den Ancker, Willemijn, van Luijn, Marvin M., Ruben, Jurjen M., Westers, Theresia M., Bontkes, Hetty J., Ossenkoppele, Gert J., de Gruijl, Tanja D., van de Loosdrecht, Arjan A.
Publicado 2010

A Human Cell Line Model for Interferon-α Driven Dendritic Cell Differentiation

por Ruben, Jurjen M., Visser, Lindy L., Heinhuis, Kimberley M., O’Toole, Tom, Bontkes, Hetty J., Westers, Theresia M., Ossenkoppele, Gert J., de Gruijl, Tanja D., van de Loosdrecht, Arjan A.
Publicado 2015

A series of case studies illustrating the role of flow cytometry in the diagnostic work‐up of myelodysplastic syndromes

por Westers, Theresia M., Saft, Leonie, van der Velden, Vincent H. J., te Marvelde, Jeroen G., Dunlop, Alan, Ireland, Robin, Valent, Peter, Porwit, Anna, Béné, Marie C., van de Loosdrecht, Arjan A.
Publicado 2022

Alternative Ii-independent antigen-processing pathway in leukemic blasts involves TAP-dependent peptide loading of HLA class II complexes

por van Luijn, Marvin M., Chamuleau, Martine E. D., Ressing, Maaike E., Wiertz, Emmanuel J., Ostrand-Rosenberg, Suzanne, Souwer, Yuri, Zevenbergen, Adri, Ossenkoppele, Gert J., van de Loosdrecht, Arjan A., van Ham, S. Marieke
Publicado 2010

Immunophenotypic aberrant hematopoietic stem cells in myelodysplastic syndromes: a biomarker for leukemic progression

por van Spronsen, Margot F., Hanekamp, Diana, Westers, Theresia M., van Gils, Noortje, Vermue, Eline, Rutten, Arjo, Jansen, Joop H., Lissenberg-Witte, Birgit I., Smit, Linda, Schuurhuis, Gerrit J., van de Loosdrecht, Arjan A.
Publicado 2023